Abercrombie (ANF) Reports Q2 Earnings: What Key Metrics Have to Say

Abercrombie & Fitch (ANF) reported Q2 2025 revenue of $1.21 billion, a 6.6% year-over-year increase that surpassed consensus estimates, with EPS of $2.32 also exceeding expectations despite a slight decline from the prior year. While total comparable store sales grew 3% in line with estimates, performance was bifurcated: the Hollister brand saw net sales jump 19.1% year-over-year and comparable sales rise 19%, significantly outperforming expectations, whereas the core Abercrombie brand experienced a 5.3% net sales decline and an 11% drop in comparable sales, missing analyst estimates. This indicates robust performance from Hollister largely offset ongoing weakness in the Abercrombie division.

Analysis

Abercrombie & Fitch (ANF) reported mixed Q2 2025 results, characterized by a significant performance divergence between its two primary brands. While the company surpassed consensus estimates with revenues of $1.21 billion (+6.6% YoY) and an EPS of $2.32, the underlying metrics reveal a bifurcated operational picture. The Hollister brand was the definitive growth engine, delivering a 19.1% year-over-year increase in net sales to $656.69 million and a remarkable 19% rise in comparable store sales, strongly outperforming the 11.7% analyst estimate. Conversely, the namesake Abercrombie brand demonstrated considerable weakness, with net sales declining 5.3% to $551.87 million and comparable sales falling 11%, a much steeper drop than the anticipated 6.3% decline. This poor performance in the core brand was masked at the consolidated level, where total comparable sales met the 3% estimate. Despite the headline beats, EPS of $2.32 marks a decline from $2.50 in the prior-year quarter, and the stock's 1.2% drop over the past month has underperformed the S&P 500, suggesting investor apprehension about the sustainability of relying solely on Hollister to drive growth.

Key Decisions for Investors

• Investors should scrutinize the stark performance gap between the Hollister and Abercrombie brands, as the company's overall health is dependent on Hollister's strong growth continuing to offset the material deterioration in the core Abercrombie segment.
• Given the year-over-year decline in EPS despite a revenue beat, it is crucial to monitor future reports for margin pressure, particularly whether the sales mix shift towards Hollister is impacting overall profitability.
• Considering the stock's recent underperformance and the significant weakness in the core brand, a neutral or hold position appears prudent until there are clear signs of a turnaround in the Abercrombie division or further acceleration at Hollister.